Neoadjuvant immunotherapy shows promise in multiple cancer types

[News]

Treating cancer with immunotherapies known as an immune checkpoint blockade (ICB) prior to surgery (so-called neoadjuvant immunotherapy) has been a rapidly growing area of research, but the scientific community is just scratching the surface of what is possible, according to a review article co-authored by several current and former investigators from the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns Hopkins Kimmel Cancer Center.

More... (https://www.news-medical.net/news/20230928/Neoadjuvant-immunotherapy-shows-promise-in-multiple-cancer-types.aspx)